Lenalidomide

CHEMBL848 Phase 4 Disetujui Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

259.3 g/mol

LogP

-0.5

Phase

4

An immunomodulatory drug used to treat multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and certain leukemias. It stimulates immune cells to attack cancer, blocks new blood vessel formation in tumors, and has direct anti-tumor effects.

Berat Molekul

259,2600 g/mol

LogP

-0,50

TPSA

92,50 Å²

Lipinski RO5

Lulus

Area Terapeutik

Ovarian Cancer Pancreatic Cancer Bladder Cancer Thyroid Cancer Pain Management Non-Small Cell Lung Cancer Melanoma Systemic Lupus Erythematosus Lymphoma Breast Cancer Chronic Pain Prostate Cancer Colorectal Cancer Leukemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O

InChI

InChI=1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18)

Molecular Formula

C13H13N3O3

HBD / HBA

2 / 4

Ikatan yang Dapat Dirotasi

1

Atom Berat

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

An immunomodulatory drug used to treat multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and certain leukemias. It stimulates immune cells to attack cancer, blocks new blood vessel formation in tumors, and has direct anti-tumor effects.

Yes, Lenalidomide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL848. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 216326. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Mencari informasi yang ramah bagi pasien?

Lenalidomide di PillFYI

Struktur

Data Cepat

Rumus: C13H13N3O3
Sinonim: 1

Tautan Eksternal

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.